Deep Genomics

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.

Deep Genomics recruits from among the top 1% of recent graduates and seasoned experts at the intersection of genomics, drug development and AI.

Number of Funding Rounds

Total Funding Amount

1

$40M

Deep Genomics has raised a total of $40M in funding over 2 rounds. Their latest funding was raised on Jan 7, 2020 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jan 7, 2020	Series B	$40M	1	—	—	Detail

Number of Lead Investors

Number of Investors

—

1

Deep Genomics is funded by 1 investors. NJF Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
NJF Capital	—	Series B